
NADMED is the world’s leading redox metabolite measurement technology offering the only CE-marked diagnostic kits for NAD⁺ and NADH, with additional kits (RUO) available for NADP⁺, NADPH, and both forms of glutathione. Developed at the University of Helsinki, NADMED technology sets the gold standard in redox analysis, combining accuracy with ease of use. Serving professional laboratories, NADMED supports research, diagnostics, and pharma globally in advancing science around metabolism, aging, and disease.
Annual Revenue$10M to $25MBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.